umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Registration in a quality register: a method to improve end-of-lifecare—a cross-sectional study
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi. (lisa.martinsson@onkologi.umu.se)
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.
Visa övriga samt affilieringar
2012 (Engelska)Ingår i: BMJ Open, ISSN 2044-6055, E-ISSN 2044-6055, Vol. 2, nr 4, artikel-id e001328Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

OBJECTIVES: Structured methods to assess and support improvement in the quality of end-of-life care are lacking and need to be developed. This need is particularly high outside the specialised palliative care. This study examines whether participation in a national quality register increased the quality of end-of-life care.

DESIGN: This study is a cross-sectional longitudinal register study.

SETTING: The Swedish Register of Palliative Care (SRPC) collects data about end-of-life care for deaths in all types of healthcare units all over Sweden. Data from all 503 healthcare units that had reported patients continuously to the register during a 3-year period were analysed. PRIMARY AND SECONDARY OUTCOME MEASURES: Data on provided care during the last weeks of life were compared year-by-year with logistic regression.

PARTICIPANTS: The study included a total 30 283 patients. The gender distribution was 54% women and 46% men. A total of 60% of patients in the study had a cancer diagnosis.

RESULTS: Provided end-of-life care improved in a number of ways. The prevalence of six examined symptoms decreased. The prescription of 'as needed' medications for pain, nausea, anxiety and death rattle increased. A higher proportion of patients died in their place of preference. The patient's next of kin was more often offered a follow-up appointment after the patient's death. No changes were seen with respect to providing information to the patient or next of kin.

CONCLUSIONS: Participation in a national quality register covariates with quality improvements in end-of-life care over time.

Ort, förlag, år, upplaga, sidor
2012. Vol. 2, nr 4, artikel-id e001328
Nationell ämneskategori
Annan hälsovetenskap
Identifikatorer
URN: urn:nbn:se:umu:diva-60750DOI: 10.1136/bmjopen-2012-001328ISI: 000315049300086PubMedID: 22936818OAI: oai:DiVA.org:umu-60750DiVA, id: diva2:562549
Tillgänglig från: 2012-10-25 Skapad: 2012-10-25 Senast uppdaterad: 2018-06-08Bibliografiskt granskad
Ingår i avhandling
1. Quality improvement in palliative care: the role of a national quality register and perceptions of information during palliative chemotherapy
Öppna denna publikation i ny flik eller fönster >>Quality improvement in palliative care: the role of a national quality register and perceptions of information during palliative chemotherapy
2015 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Introduction

There is a need in palliative care for development of structured methods to assess quality and support improvement. This need is present both within and outside specialised palliative care.

Honest information from physicians is regarded as an important part of palliative care. Information about the transition to end-of-life care (ITEOL), conveyed by physicians to patients, has also been described as a ‘breakpoint conversation’.

Quality registers enable monitoring and improvement of quality of care, and clinical research. The Swedish Register of Palliative Care (SRPC) is a Swedish national quality register that collects data from hospitals, hospices, nursing homes and home care, with an end-of-life questionnaire (ELQ) about palliative care content focusing on the last week of life.

Aims

Study I – The aim was to examine the validity of the ELQ from the SRPC.

Study II – The aim was to examine whether participation in the SRPC increases the quality of palliative care over a three-year period regarding eight items in the ELQ.

Study III – The aim was to examine whether an educational intervention for physicians and nurses in nursing homes and hospitals increases the proportion of patients who receive ITEOL.

Study IV – The aim was to describe how patients with cancer perceive the information they receive from physicians during palliative chemotherapy.

Methods

Study I – Data from 100 medical records and data from the paper versions of the ELQ filled in at a specialised palliative unit were compared with data reported to the SRPC.

Study II – Data from eight items in the ELQ reported to the SRPC from all healthcare units that had reported patients continuously during a three-year period were compared year-by-year with logistic regression.

Study III – Two municipalities (in charge of nursing homes) and two hospitals were randomised to receive an interactive half-day course about ITEOL for physicians and nurses. Four hospitals and four municipalities were assigned matched controls. The proportion of patients who received ITEOL before and after the intervention was measured with the ELQ. The effect of the intervention was analysed with a multivariable logistic regression model.

Study IV – Fifteen semi-structured interviews with patients with incurable cancer were conducted, transcribed verbatim and analysed with qualitative content analysis.

Results

Study I – The questions in the ELQ showed a congruity of 22% to 100% when comparing data from medical records with data reported to the SRPC. Eight questions fell below 80%. The paper versions filled in at the unit and the data reported to the SRPC showed a congruity of between 91% and 100%.

Study II – The prevalence of six symptoms decreased. The prescription of PRN (pro re nata – ‘as needed’) medications for pain, nausea, anxiety and death rattle increased. A higher proportion of patients died in their place of preference. The patient’s next of kin was more often offered a follow-up appointment after the patient’s death. There was no change in the proportion of patients or next of kin who received ITEOL.

Study III – The proportion of patients in the intervention group who received ITEOL increased from 35.1% (during a six-month period before the intervention) to 42.0% (during a six-month period after the intervention). The proportion in the control group increased from 30.4% to 33.7%. The effect of the intervention was significant (p=0.005) in the multivariable model.

Study IV – Three categories were disclosed during the analytical process: ‘living with a death sentence’, ‘depending on chemotherapy’, and ‘living with uncertainty’.

Conclusions

A national quality register has the potential of contributing to quality improvement in palliative care. Study I showed varied validity in the ELQ, implying a need to modify the questionnaire. Study II showed that participation in the SRPC was covariant with quality improvements in end-of-life care over time. Study III showed that more patients received ITEOL after an educative half-day intervention directed to physicians and nurses. Study IV showed that patients undergoing palliative chemotherapy perceived that their disease was incurable and deadly, and that conditions for future treatment and survival were uncertain.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå universitet, 2015. s. 99
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 1696
Nyckelord
Cancer, chemotherapy, communication, end-of-life care, oncology, palliative care, palliative medicine, quality in healthcare, quality register
Nationell ämneskategori
Cancer och onkologi
Forskningsämne
onkologi
Identifikatorer
urn:nbn:se:umu:diva-102264 (URN)978-91-7601-219-2 (ISBN)
Disputation
2015-05-22, Sal 135, byggnad 9a, Norrlands universitetssjukhus, Umeå, Umeå, 13:00 (Svenska)
Opponent
Handledare
Tillgänglig från: 2015-04-30 Skapad: 2015-04-22 Senast uppdaterad: 2018-06-07Bibliografiskt granskad

Open Access i DiVA

fulltext(251 kB)195 nedladdningar
Filinformation
Filnamn FULLTEXT02.pdfFilstorlek 251 kBChecksumma SHA-512
9dc7c1c0d76f47b689c66e1b98497657ae4edc937487e9a1fea1de031daf886631800051f17b7570000e0d2a6bf390c9fbc0791092ad821751b112fa6eba7ea1
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Martinsson, LisaNathanaelsson, LenaAxelsson, Bertil

Sök vidare i DiVA

Av författaren/redaktören
Martinsson, LisaNathanaelsson, LenaAxelsson, Bertil
Av organisationen
Onkologi
I samma tidskrift
BMJ Open
Annan hälsovetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 195 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 358 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf